Study illuminates how patients with variants in the PTPN2 gene develop IBD

Inflammatory bowel disease, or IBD, describes Crohn's disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder -; a condition in which the body's immune system attacks healthy tissues.

Related Keywords

California ,United States ,Switzerland ,University Of Southern California ,Swiss ,American ,Lars Eckmann ,Marianner Spalinger ,Vinicius Canale ,Elaine Hanson ,Timothy Chu ,Ali Shawki ,Emily Henderson ,Sharon Jahng ,Salomon Manz ,Pritha Chatterjee ,Declanf Mccole ,Rocio Alvarez ,Alinan Santos ,Golshid Sanati ,University Of California ,School Of Medicine ,Professor Of Biomedical Sciences ,California Institute Of Regenerative Medicine ,American Gastroenterological Association ,Swiss National Science Foundation ,Colitis Foundation ,Science Without Borders Program ,Molecular Gastroenterology ,Biomedical Sciences ,Anica Sayoc Becerra ,Hillmin Lei ,California Institute ,Bacteria ,Bleeding ,Fell ,Hronic ,Crohn 39s Disease ,Diarrhea ,E Coli ,Fatigue ,Astroenterology ,Gene ,Hepatology ,Immune System ,Inflammation ,Inflammatory Bowel Disease ,Medicine ,Eptides ,Research ,Stomach ,Ulcerative Colitis ,Weight Loss ,